Washington, USA
08048034998
+919359902383

Lendomy 10mg Capsule Supplier USA | Pharmaceutical Exporter from India

Lendomy 10mg Capsule: Essential Immunomodulatory Therapy for Multiple Myeloma and MDS



Are you searching for a reliable Lendomy 10 mg capsule exporter from IndiaErnest Oncology, a premier division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of specialized hematology treatments. We provide a robust supply chain to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that high-quality oncology medications reach healthcare providers and specialized pharmacies with pharmaceutical-grade integrity and regulatory precision.






Detailed Product Overview: What is Lendomy 10mg?


Lendomy 10 mg is an oral antineoplastic medication containing the active ingredient Lenalidomide. It belongs to a potent class of drugs known as Immunomodulatory Imides (IMiDs). Lenalidomide is a sophisticated derivative of thalidomide, chemically engineered to be more potent with a more favorable side-effect profile, specifically targeting the microenvironment of various blood-related cancers.

The 10mg strength is a critical component of many clinical oncology protocols. It is frequently utilized in maintenance therapy phases, dose titration for patients with renal impairment, or as part of long-term combination regimens to balance therapeutic efficacy with patient tolerability.



Primary Therapeutic Indications: 

Lendomy 10 mg is clinically indicated for several complex hematological conditions:

  • Multiple Myeloma (MM): Used in combination with dexamethasone in patients who have received at least one prior therapy, or as a foundational maintenance therapy following stem cell transplantation.

  • Myelodysplastic Syndromes (MDS): Specifically for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

  • Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after at least two prior therapies.

  • Follicular Lymphoma & Marginal Zone Lymphoma: Often used in combination with rituximab for previously treated adult patients.




Mechanism of Action: How Lendomy 10 mg Works:


Lendomy exerts its anti-cancer effects through a sophisticated multi-pathway approach.

  1. Direct Anti-Tumor Activity: It binds to the protein cereblon, which triggers the degradation of essential transcription factors. This leads to cell cycle arrest and apoptosis (programmed cell death) in malignant hematopoietic cells.

  2. Anti-Angiogenesis: It inhibits the growth of new blood vessels that tumors require for nourishment, effectively "starving" the cancer cells.

  3. Immunomodulation: It stimulates the patient’s own immune system, specifically increasing the number and activity of Natural Killer (NK) cells and T-cells to better identify and destroy malignant cells.

  4. Cytokine Regulation: It alters the production of inflammatory cytokines within the bone marrow, making the environment hostile for tumor survival.




Administration and Dosage: 


  • Route: Administered orally (capsules).

  • Schedule: Dosage is highly individualized based on the patient's condition, renal function, and blood counts. It is typically taken in 21-day or 28-day cycles.

  • Instructions: Capsules must be swallowed whole with water at the same time each day. They should never be opened, chewed, or crushed.

Safety Profile & Monitoring

Healthcare professionals must implement strict monitoring for patients on Lendomy 10 mg:

  • Embryo-Fetal Toxicity: Due to its structure, it can cause severe birth defects. Strict adherence to pregnancy prevention programs (REMS) is mandatory globally.

  • Hematologic Monitoring: Regular blood tests are required to monitor for Neutropenia (low white blood cells) and Thrombocytopenia (low platelets).

  • Venous Thromboembolism: Patients have an increased risk of blood clots; prophylactic anticoagulation is often recommended by clinicians.

  • Common Side Effects: Fatigue, diarrhea, nausea, and skin rashes.




Why source Lendomy 10 mg from Ernest Oncology?

  • Verified Supply Chain: Direct procurement from GMP-certified facilities, ensuring 100% authenticity for every exporter from India shipment.

  • Global Logistics Mastery: Expertise in handling international regulatory paperwork for the USA, UK, UAE, Australia, and South Africa. 

  • Bulk Supply Stability: We maintain a consistent inventory of 10mg capsules to ensure that global distributors can fulfill hospital tenders without delay.

  • B2B Partnership Focus: Specialized wholesale pricing and track-and-trace logistics for international pharmaceutical distributors.



📞 Contact Ernest Oncology — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

 2026-03-30T07:10:51

Keywords